**Core Concept**
High plasma protein binding refers to the phenomenon where a significant proportion of a drug's concentration is bound to plasma proteins, such as albumin and alpha-1 acid glycoprotein. This binding affects the drug's pharmacokinetics, including its distribution, metabolism, and excretion.

**Why the Correct Answer is Right**
Drugs with high plasma protein binding have a reduced volume of distribution (Vd), as the bound fraction is not available for distribution to tissues. This can lead to a reduced free fraction of the drug, which is pharmacologically active. Additionally, high protein binding can affect the drug's clearance, as the bound fraction is not accessible to metabolic enzymes. The extent of protein binding is an important factor in determining the drug's efficacy and toxicity.

**Why Each Wrong Option is Incorrect**
**Option A:**
This option is not relevant to the question and does not address the concept of plasma protein binding.

**Option B:**
This option is incorrect because high plasma protein binding does not necessarily lead to a reduced elimination half-life. In fact, some drugs with high protein binding may have a reduced clearance, leading to a longer half-life.

**Option C:**
This option is incorrect because high plasma protein binding does not directly affect the drug's receptor binding affinity. While protein binding can affect the drug's availability, it does not alter the receptor's affinity for the drug.

**Clinical Pearl / High-Yield Fact**
A high degree of plasma protein binding (usually > 90%) can lead to a reduced clearance of the drug, as the bound fraction is not accessible to metabolic enzymes. This can result in a prolonged half-life and increased risk of toxicity.

**Correct Answer:**